I do find it very irratating that the company does not give any indication of the progress of the Phase 3 Bone Marrow trials.
The last announcement was that the trials commenced in July last year.
All the announcements since give this trial virtually no promotion.
When I read the last announcement I again was frustrated, it could be 10 years before we get this one finalised by looking at the progress on the graph.
MSB play it far too safe in not communicating even vague timelines.
Given my above comments my sixth sense suggests that something is seriously wrong.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.65 |
Change
0.075(4.76%) |
Mkt cap ! $2.095B | |||
| Open | High | Low | Value | Volume |
| $1.58 | $1.65 | $1.58 | $6.251M | 3.858M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 78 | 75032 | $1.65 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.65 | 69184 | 33 |
View Market Depth
| Last trade - 15.39pm 10/07/2025 (20 minute delay) ? |
| MSB (ASX) Chart |